OnADose generates an estimated $0/month in revenue from 2–7 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-10-03).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 2–7 |
| Estimate confidence | medium |
| Pricing | Free |
| Rating | 5.00 ★ (3 ratings) |
| Category | Medical |
| Released | 01.12.2022 |
| App last updated | 18.07.2023 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · medium confidence
About
OnADose is an onabotulinumtoxinA dosing and reconstitution educational tool for spasticity, cervical dystonia, and chronic migraine. This app is intended for training use by US healthcare professionals ONLY. Patients should seek a doctor’s advice before making any medical decisions. OnabotulinumtoxinA Important Safety Information OnabotulinumtoxinA Indications Chronic Migraine -Onabotulinumtox…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 5Ratings & velocity
★ 0 in windowRating distribution
100% positive · 3 ratingsGeographic reach
best rank · 0 storefrontsRevenue & downloads trend
ARPU $0Update history
1 update tracked- v1.1.03.2y ago
Version Update includes: - Privacy Notice updates - Minor bug fixes
OnADose — FAQ
How many downloads does OnADose get?
OnADose sees an estimated 2–7 downloads per month on the App Store, per AppCurrents modeling.
Is OnADose free?
OnADose is free to download on the App Store, with no in-app purchases detected.
What is OnADose's rating?
OnADose holds a 5.00-star average from 3 ratings on the App Store.
When was OnADose released?
OnADose launched on the App Store on 01.12.2022. Its latest version shipped 18.07.2023.
